Return to study ST002251 main page
MB Sample ID: SA216723
Local Sample ID: | FIT01-146-pos |
Subject ID: | SU002337 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Age Or Age Range: | 6-17 years |
Weight Or Weight Range: | Non-exacerbation-prone IQR: 30-68 kg; Exacerbation-prone IQR: 42-63 kg |
Height Or Height Range: | Non-exacerbation-prone IQR: 131-165 cm; Exacerbation-prone IQR: 140-163 cm |
Gender: | Male and female |
Human Race: | 18 white, 189 Black, 7 more than one race, 1 Asian |
Human Ethnicity: | 2 Hispanic, 113 Not Hispanic |
Human Medications: | 92 on high-dose inhaled corticosteroids; 94 on long-acting beta adrenergic receptor agonists; 111 on Montelukast |
Human Smoking Status: | 24 exposed to tobacco smoke |
Human Inclusion Criteria: | 1) current or historical evidence of >=12% reversibility in forced expiratory volume in one second (FEV1) relative to baseline after bronchodilator administration; 2) airway hyperresponsiveness to methacholine, with a provocative concentration of methacholine causing a 20% drop in FEV1 |
Human Exclusion Criteria: | 1) premature birth before 35 weeks of gestation; 2) other chronic airway disorders that could mimic asthma. |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR002349 |
Treatment Summary: | Plasma samples were not treated with anything prior to metabolite extraction. |